The Hemodynamic and Neurohormonal Effects of Low Doses of Tezosentan (An Endothelin A/B Receptor Antagonist) in Patients with Acute Heart Failure

Gad Cotter(Momentum Research), Guillermo Torre‐Amione(Baylor College of Medicine), Maurizio Rainisio(Actelion (Switzerland)), Loı̈c Perchenet(Actelion (Switzerland)), Isaac Kobrin(Actelion (Switzerland)), Olga Milo‐Cotter(Assaf Harofeh Medical Center), Christoph Richter(University of Vienna), Jasper Dingemanse(Actelion (Switzerland)), Aline Frey(Actelion (Switzerland)), Eric Neuhart(Actelion (Switzerland)), Shoshana Kaplan(Assaf Harofeh Medical Center), Zvi Vered(Maccabi Healthcare Services), Edo Kaluski(Assaf Harofeh Medical Center), Karl Stangl(German Centre for Cardiovascular Research), Richard Pacher(University of Vienna)
European Journal of Heart Failure
August 1, 2004
10.1016/j.ejheart.2004.05.004
Cited by 58

Related Papers

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
|The Lancet|2022|1k
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation
|Journal of Biological Chemistry|2004|332
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study
|American Heart Journal|2002|323
Molecular targets of tea polyphenols in the cardiovascular system
|Cardiovascular Research|2006|241